Mai-Britt Zocca - Mar 15, 2024 Form 4 Insider Report for IO Biotech, Inc. (IOBT)

Role: Chief Executive Officer, Director
Signature: /s/ Brian Burkavage, Attorney-in-Fact for Mai-Britt Zocca
Stock symbol: IOBT
Transactions as of: Mar 15, 2024
Transactions value $: $0
Form type: 4
Date filed: 3/18/2024, 04:27 PM
Previous filing: Aug 9, 2023
Next filing: Dec 23, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IOBT	Stock Option (Right to Buy)	Award	$0	+750K		$0.00	750K	Mar 15, 2024	Common Stock	750K	$1.65	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	One-fourth of these options vest on March 15, 2025, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 25% acceleration upon termination of service by the issuer without cause and 100% acceleration upon termination of service by the Issuer without cause if such termination occurs within 24 months of a change of control.

Content

One-fourth of these options vest on March 15, 2025, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 25% acceleration upon termination of service by the issuer without cause and 100% acceleration upon termination of service by the Issuer without cause if such termination occurs within 24 months of a change of control.